Magseed localisation of non-palpable breast lesions: experience from a single centre.
Clin Radiol
; 77(4): 291-298, 2022 04.
Article
en En
| MEDLINE
| ID: mdl-35177228
ABSTRACT
AIM:
To prospectively analyse patients undergoing magnetic seed (Magseed) localisation (MSL) to evaluate the outcome, and to retrospectively compare re-excision rates for MSL with previous wire-guided localisation (WGL) to assess the hypothesis that the introduction of MSL may lead to a lower re-excision rate. MATERIALS ANDMETHODS:
MSL commenced at University Hospital Crosshouse in December 2017. No other changes were made to radiological or surgical practice during this time. Data were collected prospectively on all patients undergoing MSL between December 2017 and December 2019, in a single breast unit. Data were gathered retrospectively on patients who had undergone localised breast procedures between January 2016 and December 2019 for comparison of re-excision rates.RESULTS:
Two hundred and fifty-five patients underwent MSL surgery between December 2017 and December 2019. Of those, 98% (n=250) patients underwent successful MSL at the first attempt. The Magseed was identified intraoperatively in 100% patients and surgical excision was performed. The re-excision rate reduced from 18.9% in 2016/2017, to 11.6% in 2018/2019 (p=0.098).CONCLUSION:
In conclusion, Magseed localisation has proved to be a safe and effective way of localising breast lesions, with the advantage of high accuracy. The reduction in re-excision rates at University Hospital Crosshouse with the introduction of Magseed® localisation is a potential benefit, which requires further study.
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Radiología
/
Procedimientos de Cirugía Plástica
Tipo de estudio:
Observational_studies
Límite:
Humans
Idioma:
En
Revista:
Clin Radiol
Año:
2022
Tipo del documento:
Article